Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. 18 March 2020. Julian Goldman.

Executive Summary

US health systems are canceling elective surgeries in response to COVID-19 to preserve critical resources. See what Julian Goldman, anesthesiologist and director of the Medical Device Interoperability and Cybersecurity program at Massachusetts General Hospital, had to say about the potential ramifications.

“I think with ‘all hands on deck’ addressing a public health issue is more of an opportunity to resolve things quickly. I am very optimistic about deploying new technology capabilities in collaboration with manufacturers and the FDA.”– Julian Goldman, anesthesiologist and director of the Medical Device Interoperability and Cybersecurity program, Massachusetts General Hospital

Click here for a free trial of Medtech Insight

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT126410

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel